Brief: Longboard Pharmaceuticals Reports Third Quarter 2022 Financial Results
03/11/2022 12:47
Nov 3 (Reuters) - Longboard Pharmaceuticals Inc
LBPH.O :
* LONGBOARD PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND
REPORTS
THIRD QUARTER 2022 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE $0.68
* EXPECTED CASH RUNWAY INTO 2024
Source text for Eikon: ID:nBw713wWqa
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions